• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Guardant Health (GH)

Common Shares
Sell: $46.85|Buy: $49.68|Change: 2.02 (-4.13%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD,test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Address

505 Penobscot Drive
Redwood City
CA
USA
94063

Telephone

+1 855 6988887

Website

https://www.guardanthealth.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Guardant Health Inc First Quarter Earnings Conference Call for 20262026-04-30T16:30:00
Guardant Health Inc First Quarter Earnings Results for 20262026-04-30T00:00:00
Guardant Health Inc Fourth Quarter Earnings Conference Call for 20252026-02-20T16:30:00
Guardant Health Inc Fourth Quarter Earnings Results for 20252026-02-20T00:00:00
Guardant Health Inc Annual Report for 20252026-02-20T00:00:00
Guardant Health Inc Third Quarter Earnings Conference Call for 20252025-11-06T16:30:00
Guardant Health Inc Third Quarter Earnings Results for 20252025-11-06T00:00:00
Guardant Health Inc Second Quarter Earnings Conference Call for 20252025-08-07T16:30:00
Guardant Health Inc Second Quarter Earnings Results for 20252025-08-07T00:00:00
Guardant Health Inc Annual General Meeting for 20252025-06-12T09:30:00

Previous key dates

NameKey Date
Guardant Health Inc First Quarter Earnings Conference Call for 20252025-04-30T16:30:00
Guardant Health Inc First Quarter Earnings Result for 20252025-04-30T00:00:00
Barclays 27th Annual Global Healthcare Conference2025-03-12T13:30:00
Leerink Partners Global Health Conference2025-03-11T16:20:00
TD Cowen 45th Annual Health Care Conference2025-03-04T10:30:00
Guardant Health Inc Fourth Quarter Earnings Conference Call for 20242025-02-20T16:30:00
Guardant Health Inc Fourth Quarter Earnings Results for 20242025-02-20T00:00:00
Guardant Health Inc Annual Report for 20242025-02-20T00:00:00
Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference2025-01-13T19:30:00
Guardant Health Inc Piper Sandler Healthcare Conference 20242024-12-03T08:30:00
Guardant Health Inc Jefferies London Healthcare Conference 20242024-11-20T07:30:00
Guardant Health Inc Guggenheim Inaugural Healthcare Innovation Conference 20242024-11-12T10:30:00
Guardant Health Inc Third Quarter Earnings Conference Call for 20242024-11-06T16:30:00
Guardant Health Inc Third Quarter Earnings Result for 20242024-11-06T00:00:00
Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference2024-09-05T11:30:00
Guardant Health Inc Second Quarter Earnings Conference Call for 20242024-08-07T16:30:00
Guardant Health Inc Second Quarter Earnings Result for 20242024-08-07T00:00:00
Guardant Health Inc Annual General Meeting for 20242024-06-12T09:30:00
Guardant Health Inc Goldman Sachs 45th Annual Global Healthcare Conference 20242024-06-11T14:00:00
Guardant Health Inc Jefferies Global Healthcare Conference 20242024-06-05T17:00:00
Guardant Health Inc William Blair 44th Annual Growth Stock Conference 20242024-06-04T16:20:00
Guardant Health, Inc. to participate in the Leerink Partners 2024 Healthcare Crossroads Conference2024-05-29T16:00:00
Real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week2024-05-20T12:30:00
Guardant Health, Inc. to participate in the BofA Securities 2024 Healthcare Conference2024-05-15T13:40:00
Guardant Health Inc First Quarter Earnings Conference Call for 20242024-05-09T16:30:00
Guardant Health Inc First Quarter Earnings Result for 20242024-05-09T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.